Prostate Cancer Diagnosis and Therapy Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Therapy Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Therapy Market Perspective (2018-2032)
2.2 Prostate Cancer Diagnosis and Therapy Growth Trends by Region
2.2.1 Prostate Cancer Diagnosis and Therapy Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Prostate Cancer Diagnosis and Therapy Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Region (2023-2032)
2.3 Prostate Cancer Diagnosis and Therapy Market Dynamics
2.3.1 Prostate Cancer Diagnosis and Therapy Industry Trends
2.3.2 Prostate Cancer Diagnosis and Therapy Market Drivers
2.3.3 Prostate Cancer Diagnosis and Therapy Market Challenges
2.3.4 Prostate Cancer Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnosis and Therapy Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Therapy Revenue
3.4 Global Prostate Cancer Diagnosis and Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Therapy Revenue in 2022
3.5 Prostate Cancer Diagnosis and Therapy Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnosis and Therapy Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnosis and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Therapy Breakdown Data by Type
4.1 Global Prostate Cancer Diagnosis and Therapy Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Type (2023-2032)
5 Prostate Cancer Diagnosis and Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Diagnosis and Therapy Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Prostate Cancer Diagnosis and Therapy Market Size (2018-2032)
6.2 North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Therapy Market Size (2018-2032)
7.2 Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size (2018-2032)
8.2 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnosis and Therapy Market Size (2018-2032)
9.2 Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size (2018-2032)
10.2 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Prostate Cancer Diagnosis and Therapy Introduction
11.1.4 AbbVie Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Prostate Cancer Diagnosis and Therapy Introduction
11.2.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Prostate Cancer Diagnosis and Therapy Introduction
11.3.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Prostate Cancer Diagnosis and Therapy Introduction
11.4.4 Bayer Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Dendreon Pharmaceuticals
11.5.1 Dendreon Pharmaceuticals Company Detail
11.5.2 Dendreon Pharmaceuticals Business Overview
11.5.3 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Introduction
11.5.4 Dendreon Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.5.5 Dendreon Pharmaceuticals Recent Development
11.6 Ferring
11.6.1 Ferring Company Detail
11.6.2 Ferring Business Overview
11.6.3 Ferring Prostate Cancer Diagnosis and Therapy Introduction
11.6.4 Ferring Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.6.5 Ferring Recent Development
11.7 Ipsen Pharma
11.7.1 Ipsen Pharma Company Detail
11.7.2 Ipsen Pharma Business Overview
11.7.3 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Introduction
11.7.4 Ipsen Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.7.5 Ipsen Pharma Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Introduction
11.8.4 Johnson and Johnson Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.8.5 Johnson and Johnson Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Prostate Cancer Diagnosis and Therapy Introduction
11.9.4 Sanofi Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Tolmar Pharmaceuticals
11.10.1 Tolmar Pharmaceuticals Company Detail
11.10.2 Tolmar Pharmaceuticals Business Overview
11.10.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Introduction
11.10.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
11.10.5 Tolmar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Hormone Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Biologic Therapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Prostate Cancer Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global Prostate Cancer Diagnosis and Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 8. Global Prostate Cancer Diagnosis and Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prostate Cancer Diagnosis and Therapy Market Share by Region (2018-2023)
Table 10. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 11. Global Prostate Cancer Diagnosis and Therapy Market Share by Region (2023-2032)
Table 12. Prostate Cancer Diagnosis and Therapy Market Trends
Table 13. Prostate Cancer Diagnosis and Therapy Market Drivers
Table 14. Prostate Cancer Diagnosis and Therapy Market Challenges
Table 15. Prostate Cancer Diagnosis and Therapy Market Restraints
Table 16. Global Prostate Cancer Diagnosis and Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prostate Cancer Diagnosis and Therapy Market Share by Players (2018-2023)
Table 18. Global Top Prostate Cancer Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Therapy as of 2022)
Table 19. Ranking of Global Top Prostate Cancer Diagnosis and Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnosis and Therapy Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnosis and Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnosis and Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 28. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Type (2023-2032)
Table 29. Global Prostate Cancer Diagnosis and Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Prostate Cancer Diagnosis and Therapy Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 32. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Application (2023-2032)
Table 33. North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032) & (US$ Million)
Table 35. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032) & (US$ Million)
Table 37. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size by Region (2023-2032) & (US$ Million)
Table 39. Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 40. Latin America Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032) & (US$ Million)
Table 41. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Country (2023-2032) & (US$ Million)
Table 43. AbbVie Company Detail
Table 44. AbbVie Business Overview
Table 45. AbbVie Prostate Cancer Diagnosis and Therapy Product
Table 46. AbbVie Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 47. AbbVie Recent Development
Table 48. Astellas Pharma Company Detail
Table 49. Astellas Pharma Business Overview
Table 50. Astellas Pharma Prostate Cancer Diagnosis and Therapy Product
Table 51. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 52. Astellas Pharma Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Prostate Cancer Diagnosis and Therapy Product
Table 56. AstraZeneca Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Bayer Company Detail
Table 59. Bayer Business Overview
Table 60. Bayer Prostate Cancer Diagnosis and Therapy Product
Table 61. Bayer Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 62. Bayer Recent Development
Table 63. Dendreon Pharmaceuticals Company Detail
Table 64. Dendreon Pharmaceuticals Business Overview
Table 65. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product
Table 66. Dendreon Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 67. Dendreon Pharmaceuticals Recent Development
Table 68. Ferring Company Detail
Table 69. Ferring Business Overview
Table 70. Ferring Prostate Cancer Diagnosis and Therapy Product
Table 71. Ferring Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 72. Ferring Recent Development
Table 73. Ipsen Pharma Company Detail
Table 74. Ipsen Pharma Business Overview
Table 75. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product
Table 76. Ipsen Pharma Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 77. Ipsen Pharma Recent Development
Table 78. Johnson and Johnson Company Detail
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product
Table 81. Johnson and Johnson Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 82. Johnson and Johnson Recent Development
Table 83. Sanofi Company Detail
Table 84. Sanofi Business Overview
Table 85. Sanofi Prostate Cancer Diagnosis and Therapy Product
Table 86. Sanofi Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Tolmar Pharmaceuticals Company Detail
Table 89. Tolmar Pharmaceuticals Business Overview
Table 90. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product
Table 91. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 92. Tolmar Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnosis and Therapy Market Share by Type: 2022 VS 2032
Figure 2. Hormone Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Biologic Therapy Features
Figure 5. Targeted Therapy Features
Figure 6. Global Prostate Cancer Diagnosis and Therapy Market Share by Application in 2022 & 2032
Figure 7. General Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Prostate Cancer Diagnosis and Therapy Report Years Considered
Figure 10. Global Prostate Cancer Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 11. Global Prostate Cancer Diagnosis and Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 12. Global Prostate Cancer Diagnosis and Therapy Market Share by Region: 2022 VS 2032
Figure 13. Global Prostate Cancer Diagnosis and Therapy Market Share by Players in 2022
Figure 14. Global Top Prostate Cancer Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue in 2022
Figure 16. North America Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 17. North America Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2032)
Figure 18. United States Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Canada Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2032)
Figure 22. Germany Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. France Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. U.K. Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Italy Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Russia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Nordic Countries Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Prostate Cancer Diagnosis and Therapy Market Share by Region (2018-2032)
Figure 30. China Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Japan Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. South Korea Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. India Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Australia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2032)
Figure 38. Mexico Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Brazil Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Share by Country (2018-2032)
Figure 42. Turkey Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Saudi Arabia Prostate Cancer Diagnosis and Therapy Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 45. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 46. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 47. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 48. Dendreon Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 49. Ferring Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 50. Ipsen Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 51. Johnson and Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 52. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 53. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Therapy Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
